Search results
Results from the Health.Zone Content Network
A report published in March of 2022, for example, identified 12,247 reported cases of tinnitus after COVID-19 vaccination up through September 2021.
fever. headache. muscle pain. nausea. pain at the injection site. redness at the injection site. swelling at the injection site. According to the CDC, some people experience more side effects ...
Takeaways. If you have been exposed to someone with COVID-19, you may begin to show symptoms after a 3-5 day incubation period. The amount of time will depend on the variant you were exposed to ...
Slight fever and chills. Chest discomfort. Cold symptoms, such as a mild headache or body aches. You might have a cough for a few weeks or months after your other symptoms clear up. To be on the ...
There are more than 80 different autoimmune diseases, including: type 1 diabetes. lupus. rheumatoid arthritis. psoriasis. inflammatory bowel disease. multiple sclerosis. These chronic conditions ...
The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States. The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, [7] and mass vaccinations began four days later.
e. The Oxford–AstraZeneca COVID‑19 vaccine, sold under the brand names Covishield [31] and Vaxzevria [1] [32] among others, is a viral vector vaccine for the prevention of COVID-19. It was developed in the United Kingdom by Oxford University and British-Swedish company AstraZeneca, [33] [34] [35] using as a vector the modified chimpanzee ...
The vaccine should slow the spread of COVID-19 around the world. Fewer people should get sick, and more lives can be saved. The Pfizer, Moderna, and Novavax vaccines have been shown to be at least ...